T. Rowe Price Associates’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Buy |
53,137
+9,360
| +21% | +$20.6K | ﹤0.01% | 2861 |
|
|
2025
Q1 | $51K | Hold |
43,777
| – | – | ﹤0.01% | 2926 |
|
|
2024
Q4 | $56K | Sell |
43,777
-21,041
| -32% | -$26.9K | ﹤0.01% | 2913 |
|
|
2024
Q3 | $222K | Buy |
64,818
+12,363
| +24% | +$42.3K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $245K | Buy |
52,455
+2,751
| +6% | +$12.8K | ﹤0.01% | 2507 |
|
|
2024
Q1 | $369K | Buy |
49,704
+7,174
| +17% | +$53.3K | ﹤0.01% | 2335 |
|
|
2023
Q4 | $431K | Sell |
42,530
-1,262
| -3% | -$12.8K | ﹤0.01% | 2237 |
|
|
2023
Q3 | $342K | Buy |
43,792
+8,099
| +23% | +$63.3K | ﹤0.01% | 2282 |
|
|
2023
Q2 | $294K | Buy |
35,693
+586
| +2% | +$4.83K | ﹤0.01% | 2365 |
|
|
2023
Q1 | $255K | Buy |
35,107
+4,880
| +16% | +$35.4K | ﹤0.01% | 2423 |
|
|
2022
Q4 | $268K | Sell |
30,227
-4,381
| -13% | -$38.8K | ﹤0.01% | 2410 |
|
|
2022
Q3 | $424K | Buy |
34,608
+3,848
| +13% | +$47.1K | ﹤0.01% | 2205 |
|
|
2022
Q2 | $364K | Buy |
30,760
+5,758
| +23% | +$68.1K | ﹤0.01% | 2355 |
|
|
2022
Q1 | $476K | Buy |
25,002
+1,429
| +6% | +$27.2K | ﹤0.01% | 2353 |
|
|
2021
Q4 | $626K | Sell |
23,573
-19,395
| -45% | -$515K | ﹤0.01% | 2284 |
|
|
2021
Q3 | $1.77M | Buy |
42,968
+4,324
| +11% | +$178K | ﹤0.01% | 1783 |
|
|
2021
Q2 | $2.19M | Buy |
38,644
+6,683
| +21% | +$379K | ﹤0.01% | 1699 |
|
|
2021
Q1 | $1.34M | Buy |
31,961
+5,023
| +19% | +$211K | ﹤0.01% | 1899 |
|
|
2020
Q4 | $1.89M | Buy |
26,938
+12,165
| +82% | +$853K | ﹤0.01% | 1658 |
|
|
2020
Q3 | $415K | Buy |
+14,773
| New | +$415K | ﹤0.01% | 2165 |
|
|
2019
Q2 | – | Sell |
-287,826
| Closed | -$7.04M | – | 2539 |
|
|
2019
Q1 | $7.04M | Sell |
287,826
-237,063
| -45% | -$5.8M | ﹤0.01% | 1361 |
|
|
2018
Q4 | $11.9M | Sell |
524,889
-247,819
| -32% | -$5.64M | ﹤0.01% | 1282 |
|
|
2018
Q3 | $24.6M | Sell |
772,708
-11,197
| -1% | -$356K | ﹤0.01% | 1157 |
|
|
2018
Q2 | $28.1M | Sell |
783,905
-108,454
| -12% | -$3.89M | ﹤0.01% | 1082 |
|
|
2018
Q1 | $29.6M | Sell |
892,359
-5,312
| -0.6% | -$176K | ﹤0.01% | 1046 |
|
|
2017
Q4 | $27.6M | Sell |
897,671
-337,670
| -27% | -$10.4M | ﹤0.01% | 1067 |
|
|
2017
Q3 | $29.7M | Sell |
1,235,341
-225,389
| -15% | -$5.41M | 0.01% | 1040 |
|
|
2017
Q2 | $24.5M | Buy |
1,460,730
+59,034
| +4% | +$991K | ﹤0.01% | 1095 |
|
|
2017
Q1 | $31.3M | Sell |
1,401,696
-229,838
| -14% | -$5.13M | 0.01% | 975 |
|
|
2016
Q4 | $26.5M | Sell |
1,631,534
-242,862
| -13% | -$3.94M | 0.01% | 1032 |
|
|
2016
Q3 | $25.3M | Buy |
1,874,396
+460,280
| +33% | +$6.2M | 0.01% | 1048 |
|
|
2016
Q2 | $33.5M | Buy |
1,414,116
+4,220
| +0.3% | +$99.9K | 0.01% | 921 |
|
|
2016
Q1 | $47.2M | Buy |
+1,409,896
| New | +$47.2M | 0.01% | 790 |
|